In the case of Humira, the medication can be given at home by injection, either in a self-injecting pen or with a syringe. A ...

Medically reviewed by Brendan Camp, MD Hidradenitis suppurativa (HS) is a chronic (long-term) condition that causes painful ...

Humira is a versatile drug used to treat multiple ... designed to decrease injection volume for higher doses and also reduce pain at the injection site. The high-concentration version currently ...

As pharmaphorum recently reported, the entrance of biosimilars to Humira is a significant event ... aiming to cut injection volume by half and result in fewer injections in particular patients.

If you have any questions, ask your doctor or pharmacist. Inject this medication under the skin as directed by your doctor, usually every other week or once a week in some cases. The injection is ...

Opinions expressed by Forbes Contributors are their own. Joshua Cohen is a Boston-based writer who covers health policy. In a unique challenge to drug makers, the Dutch Pharmaceutical ...

Mercks Keytruda tops global pharmaceutical sales as Humira drops out of top 10 Mercks cancer drug dominates global sales ...

possible malignancies and COPD exacerbation Adalimumab (Humira®) Injection site reactions and upper respiratory tract infections Serious bacterial infections, unusual infections (tuberculosis and ...

FDA confirms end of Zepbound shortage, but announces new shortages for other medications, including Humira biosimilar and painkillers. Details here.

Yesterday, Amgen announced that it would launch the U.S.’s first marketed Humira-referenced biosimilar, Amjevita (adalimumab-atto), at two different list prices: $3,288 and $1,557 per 40 mg pen ...